A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
Clinical trial NCT06860971 · RECRUITING
Trial details
- NCT number
- NCT06860971
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-18
- Primary completion
- 2027-01-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.